[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.92.62. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
October 1995

Aggressive Squamous Cell Carcinomas in Patients Treated With Extracorporeal Photopheresis for Cutaneous T-Cell Lymphoma

Author Affiliations

New York

Dermatology Service New York Veterans Affairs Medical Center 423 E 23rd St New York, NY 10010

Arch Dermatol. 1995;131(10):1211-1212. doi:10.1001/archderm.1995.01690220119029
Abstract

Actinically derived squamous cell carcinomas arising in light-complected individuals who have had extensive lifetime sun exposure are typically not aggressive. The cutaneous squamous cell carcinomas arising in patients receiving chronic immunosuppressive therapy or with underlying lymphoproliferative disorders, however, follow an aggressive course. These neoplasms occur with greater frequency, are often multiple or eruptive, and display a high metastatic potential. 1 Cutaneous T-cell lymphoma has not been found to intrinsically predispose individuals to second cutaneous malignancies.2 When these patients are treated with long-term topical mechlorethamine or psoralen and UV-A photochemotherapy, however, the relative risk of developing nonaggressive cutaneous squamous cell carcinomas increases.3,4 A new form of therapy for erythrodermic cutaneous T-cell lymphoma is extracorporeal photopheresis. It has many immunomodulatory effects but is not known to cause immunosuppression or cutaneous malignancies. In a recent review of the 149 patients with cutaneous T-cell lymphoma treated with photopheresis who have been described

First Page Preview View Large
First page PDF preview
First page PDF preview
×